Organon is a pharmaceutical company focusing on women's health, biosimilars, and established brands. Newly established in 2021 with headquarters in the United States, the company aims to improve and maintain the everyday health of women. Led by CEO Kevin Ali, Organon operates with a mission to make a better and healthier life for every woman.
With only 158 employees and an annual revenue of $23 million, Organon is considered a small company within its industry. However, it remains dedicated to its cause despite facing competition from larger pharmaceutical companies such as AstraZeneca, Boehringer Ingelheim, and Allergan plc. Offering an average employee salary of $73,941, Organon continues to grow and make strides within the pharmaceutical sector.
